Key result
KCNQ1 polymorphisms are linked to ~149% higher CVD risk but not T2D.
Why the study?
Polymorphisms within the KCNQ1 gene are consistently associated with type 2 diabetes, but their association with cardiovascular disease in the Saudi Arabian population was unclear.
Are KCNQ1 polymorphisms associated with an increased risk of CVD and T2D in the Saudi Arabian population?
Case-Control (n=1,146)
Are KCNQ1 polymorphisms associated with an increased risk of CVD and T2D in the Saudi Arabian population?
Odds Ratio: 2.49 (95% CI 1.72–3.61)
p-value: p=< 0.0001
KCNQ1 polymorphisms rs151290 and rs2237895 are strongly associated with cardiovascular disease risk in the Saudi Arabian population, independent of type 2 diabetes.
KCNQ1 variants were associated with CVD but not T2D; leaves open generalizability and clinical relevance pending larger replication.
Genome-wide association studies have identified several loci associated with an increased risk for cardiovascular disease (CVD) and type 2 diabetes (T2D). Polymorphisms within the KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) gene are consistently associated with T2D in a number of populations. The current study was undertaken to evaluate the association of 3 polymorphisms of KCNQ1 (rs2237892, rs151290 and rs2237895) with T2D and/or CVD. Patients diagnosed with either T2D (320 patients), CVD (250 patients) or both (60 patients) and 516 healthy controls were genotyped by TaqMan assay run on a real time PCR thermocycler. A statistically significant association was found for SNPs rs151290 (OR = 1.76; 95%CI = 1.02-3.05; p = 0.0435) and rs2237895 (OR = 2.49; 95%CI = 1.72-3.61; p < 0.0001) with CVD. SNP rs151290 (OR = 7.43; 95%CI = 1.00-55.22; p = 0.0499) showed a strong association in patients with both T2D and CVD. None of the SNPs showed any significant association with T2D. Haploview analysis showed that the ACC (rs151290, rs2237892 and rs2237895) haplotype is the most significant risk allele combination for CVD, while CCA is the most significant risk haplotype for co-morbidity with T2D. KCNQ1 polymorphism at SNPs rs151290 and rs2237895 is strongly associated with CVD in this population, but presented no association with T2D.
No takes yet. Share an insight, caveat, or question.
Al-Shammari et al. (2017) conducted a case-control in Cardiovascular disease and Type 2 diabetes (n=1,146). KCNQ1 polymorphisms (rs151290 and rs2237895) vs. Healthy controls was evaluated on Cardiovascular disease (OR 2.49, 95% CI 1.72-3.61, p=< 0.0001). KCNQ1 polymorphisms, particularly rs2237895, were strongly associated with an increased risk of cardiovascular disease (OR 2.49; 95% CI 1.72-3.61; p < 0.0001) but showed no association with T2D.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: